CANNAPHARMARX, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CANNAPHARMARX, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $130.35K, a 74.29% decline year-over-year.
- CANNAPHARMARX, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $64.03K, a 80.57% decline year-over-year.
- CANNAPHARMARX, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $507.01K, a 1.02% increase year-over-year.
- CANNAPHARMARX, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $348.75K, a 126.09% increase year-over-year.
- CANNAPHARMARX, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $866.70K, a 42.40% decline from fiscal 2022.
- CANNAPHARMARX, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $1.50M, a 13.81% increase from fiscal 2021.
- CANNAPHARMARX, INC. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $1.32M.
- CANNAPHARMARX, INC. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $2.20M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-03-31 | $130.35K 10-Q · filed 2024-06-25 | |
| 2023-12-31 | $866.70K 10-K · filed 2025-04-10 | |
| 2023-06-30 | $64.03K 10-Q · filed 2023-11-17 | |
| 2023-03-31 | $507.01K 10-Q · filed 2024-06-25 | |
| 2022-12-31 | $1.50M 10-K · filed 2023-09-01 | |
| 2022-09-30 | $348.75K 10-Q · filed 2023-11-17 | |
| 2022-06-30 | $329.60K 10-Q · filed 2023-11-17 | |
| 2022-03-31 | $501.92K 10-Q · filed 2023-11-17 | |
| 2021-12-31 | $1.32M 10-K · filed 2023-09-01 | |
| 2021-09-30 | $154.26K 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $764.35K 10-Q · filed 2022-11-21 | |
| 2021-03-31 | $474.86K 10-Q · filed 2022-11-21 | |
| 2019-12-31 | $2.20M 10-K · filed 2021-04-14 | |
| 2019-03-31 | $2.20M 10-Q · filed 2020-11-12 |